This exclusive marcus evans conference will be a three-daylong physical/online event wherein the attendees can enjoy networking with one another and hear insights from Bayer, Merck, Janssen/Johnson, Roche, Novartis Institute for Biomedical Research, Leo-Pharma and many others on key industry topics such as:
• Assess new opportunities in drug development
• Innovate and invent new models for boosting performance and r&d productivity
• Involve data analytics into PPM strategy from research to commercial phases
• Align R&D and Portfolio Strategy and motivate your organisation to invest in long-term planning and capacity management
• Balance scientific (data-driven) vs. commercial considerations (aspirational) in portfolio prioritization
• Enhance project, program, and portfolio visibility to improve R&D Performance
• Choose the right structure and methodology to support project planning
• Accelerate investment in data sciences for better, more connected R&D insights
This conference is attended by heads, VPs, Senior Managers of Big Pharma, Biotech, Public Insitutions/Research Centers:
· Project and/or Portfolio Management
· Project / Strategic Planning
· Project and/or Portfolio Analysis
· Project and/or Portfolio Valuation
· Business/ Corporate/ Strategic Development
· Product Development
· Pipeline Management/ Pipeline Portfolio
· Investment/ Decision Support
· Alliance management / Business Development
Special Discounts are available for Swiss Biotech Association Members! To take advantage of the discounts use the contact form.
00
Days00
Hours00
MinutesBerlin, Germany